Skip to main content

Ronald Borchardt, Ismael Hidalgo, Kelli Richard, Per Peterson, Louis Drapeau

The Society for Biomolecular Sciences has awarded the SBS Polypops Award to Ronald Borchardt, the Solon Summerfield Distinguished Professor of pharmaceutical chemistry at the University of Kansas School of Pharmacy, and Ismael Hidalgo of Absorption Systems, for their discovery and development of Caco-2 cells, a human colon carcinoma cell line as a model of the intestinal mucosa.
The SBS will present the award at its 13th Annual SBS Conference & Exhibition in Montreal, Canada, on April 19. The award includes recognition in The Journal of Biomolecular Screening and a $2,500 honorarium.
Borchardt’s and Hidalgo’s research stems from a paper they published in Gastroenterology in 1989 in which they concluded that “Caco-2 cells grown on collagen-coated polycarbonate membranes should represent a valuable transport model system for the small intestinal epithelium.”

Invitrogen last week said it has promoted Kelli Richard to be vice president of finance and chief accounting officer, and that Per Peterson has joined the company’s board of directors.
Before joining Invitrogen in 2005, Richard spent 14 years in accounting and financial reporting, and was vice president of accounting and reporting and a principal accounting officer at Gateway.
Peterson recently retired from his role as chairman of research and development at Johnson & Johnson. Before that he was the head of the molecular immunogenetics department and chairman of the department of immunology at the Scripps Research Institute.

Bio-Rad Laboratories said that the appointment of Louis Drapeau to the board of directors brings the company back in line with American Stock Exchange listing rules governing the number of directors who must sit on the board’s audit committee.
The company was left with an empty seat on that committee when board member Philip Padou died late in 2006.
Drapeau will face official election to the post at a board meeting in late April.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.